CDSL: CDSL plunges 6% as Standard Chartered exits in Rs 1,712.9-cr block deal
The Standard Chartered Bank offloaded its 9.6% stake in CDSL and worth of $151 million nearly 1Crore shares . CDSL Shares plummeted 6% today after the Shares offloaded by one of the Foreign investors in the company.
CENTRAL DEPOSITORY Market Price is moving in box pattern and market has reached support area of the pattern
Standard Chartered Bank reportedly exits, aiming for $151 million from its entire 7.18% stake. CDSL, one of India’s two depositories and the only listed one, has BSE India as a promoter with a 15% ownership. Foreign portfolio investors in Category-I own over 10%, while insurance companies and mutual funds hold about 8% and nearly 13%, respectively.
AstraZeneca Pharma: AstraZeneca Pharma gains 4% after CDSCO approval for cancer drug import
The Astra Zeneca Pharma received the rights from central Drug Board in India for imports of Cancer drug in India for Sales and Distribution. This Drug is mainly used for Breast cancer treatments.
ASTRAZENECA PHARMA Market Price is moving in Ascending channel and market has fallen from the higher high area of the channel
The shares of AstraZeneca Pharma India experienced a significant surge of over 4 percent. This increase followed the company’s announcement that it had obtained approval from the Central Drugs Standard Control Organisation (CDSCO) to import, sell, and distribute Trastuzumab deruxtecan lyophilized powder concentrate for solution for infusion 100mg, known as Enhertu.
Trastuzumab deruxtecan is specifically indicated for the treatment of adult patients diagnosed with unresectable or metastatic HER2-Low (IHC 1+ or IHC 2+/ISH-) breast cancer, who have previously undergone chemotherapy in the metastatic setting or have experienced disease recurrence during or within 6 months of completing adjuvant chemotherapy. Additionally, the drug is indicated for the treatment of adult patients with locally advanced or metastatic HER2-positive gastric or gastroesophageal junction (GEJ) adenocarcinoma, who have previously received a trastuzumab-based regimen.
AstraZeneca Pharma expressed its optimism regarding the receipt of this permission, stating that it sets the stage for the launch of Trastuzumab deruxtecan lyophilized powder concentrate for solution for infusion 100mg (Enhertu) in India for the specified additional indications, subject to obtaining any related statutory approvals.
Over the past year, the stock has witnessed a remarkable rise of 57 percent, outperforming the benchmark Nifty 50, which rose by 30 percent during the same period.
The Shyam Metallics company received a license for Composite Surjagad-1 iron Ore Block in Maharastra, Area is 1526 hectares for Iron ore extraction by joint venture with National energy and conservation limited. The Company said we have to guarantee for Environmental Safety and growth will be protected by this Iron Ore extraction.
SHYAM METALICS AND ENGY Market Price is moving in uptrend line and market has rebounded from the higher low area of the pattern
Shyam Metalics share price rises 2% as it secures composite license for Surjagad-1 iron ore block in Maharashtra on March 27.
The joint venture, Natural Resources Energy Private Limited (NREPL), received the Letter of Intent (LoI), with Dorite Tracon Private Limited, a promoter of Shyam Metalics, holding 49% of the economic interest in NREPL.
The composite license pertains to the Surjagad 1 Iron Ore Block, spanning 1,526 hectares in Angudra, Ramunkal Meta, Puske Meta, Negal Meta village, Etapalli Taluka, and Gadchiroli District.
The LoI is valid for one year, during which NREPL will fulfill all conditions to secure the final composite license from the Government of Maharashtra.
B Bhushan, VCMD of Shyam Metalics and Energy Limited, highlighted the collaborative efforts with Sarda Energy & Minerals Ltd, aiming for growth and development in Maharashtra’s mining sector.
Additionally, Shyam Metalics announced a greenfield expansion project focusing on aluminium flat-rolled products, with an investment of Rs 450 crore, contributing to capacity expansion.
Don’t trade all the time, trade forex only at the confirmed trade setups.
Get more confirmed trade setups here: forexgdp.com/buy/
